Skip to main content
. 2018 Aug 1;7(9):651–663. doi: 10.1002/sctm.18-0024

Figure 1.

Figure 1

Mesenchymal stem cell (MSC)‐based drug delivery strategies. The tumor tropism of MSCs can be exploited to deliver a wide variety of therapeutic agents for the treatment of cancer, such as apoptosis‐inducing agents, cytotoxic chemotherapy, anti‐angiogenic factors, immunomodulatory agents, oncolytic viruses, drug‐loaded nanoparticles/microparticles, and tissue‐ or tumor‐specific prodrugs.